Latest Strategy Changes News

Maas Group Holdings is selling its Construction Materials division for $1.7 billion to Heidelberg Materials Australia, marking a strategic pivot towards electrification, digital infrastructure, and AI-led growth.

Beach Energy reported a resilient first half of FY26, overcoming Cooper Basin floods to deliver solid earnings boosted by LNG cargoes and higher gas prices. The company’s operational safety and environmental efforts underpin a confident outlook as key projects ramp up.

Beach Energy reported a 32% drop in half-year net profit to $150.2 million, impacted by flooding and lower oil prices, while advancing its Waitsia Stage 2 gas project. The company declared a fully franked interim dividend of 1.0 cent per share.

Maas Group Holdings has agreed to sell its Construction Materials division for up to $1.703 billion, marking a strategic pivot towards digital infrastructure and electrification sectors. The deal, expected to close in late 2026, includes a significant minority investment in AI infrastructure developer Firmus Grid.

BCAL Diagnostics has launched its Avantect blood tests for pancreatic and ovarian cancer with encouraging early uptake and is advancing its BREASTESTplus breast cancer test towards broader clinical use.

OFX Group Limited has initiated a strategic review to explore growth and sale options while reporting softer 3Q FY26 earnings impacted by macroeconomic challenges. The company also announced the resignation of its CFO, signaling a period of transition.

Prairie Lithium has retracted its previous production target citing compliance issues, while announcing a binding offtake agreement with South Korea’s Hydro Lithium for its Phase 1 lithium output. This move signals a strategic shift towards selling intermediate lithium products to reduce costs and accelerate market entry.

Elevate Uranium has announced a significant upgrade to its Marenica Uranium Project in Namibia, doubling the resource grade and increasing contained uranium. This milestone enhances the project's development prospects and underpins the company's growth strategy.

Jcurve Solutions has reported a robust first half of FY26, posting a 32% increase in revenue and a remarkable 478% jump in EBITDA, while upgrading its full-year revenue guidance amid ongoing customer churn challenges.

The US Congress has reauthorized the Rare Pediatric Disease Priority Review Voucher program through September 2029, a move that could significantly benefit Neuren Pharmaceuticals as it advances its rare disease drug candidates.

Codeifai Limited has raised $1.1 million through a share placement that coincided with a sharp increase in its share price, confirming full compliance with ASX disclosure rules following a detailed inquiry.

Lake Resources has clarified its latest cash flow report, highlighting $666k spent on environmental and power solution explorations while advancing key regulatory approvals for its Kachi lithium project. The company maintains a robust liquidity position and benefits from new technology partnerships aimed at reducing costs.